Atlas Trials

Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma

Clinical trial NCT02342782 · COMPLETED

Trial details

NCT number
NCT02342782
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Mature T- and NK-Cell Non-Hodgkin LymphomaRefractory Mature T-Cell and NK-Cell Non-Hodgkin LymphomaRecurrent Cutaneous T-Cell Non-Hodgkin LymphomaRefractory Cutaneous T-Cell Non-Hodgkin Lymphoma
Start date
2020-06-08
Primary completion
2020-09-18
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.